Morgan Stanley Call 260 JNJ 19.12.../ DE000MB9R2A5 /
08/11/2024 18:49:14 | Var.+0.002 | Denaro22:00:02 | Lettera22:00:02 | Sottostante | Prezzo di esercizio | Expiration date | Tipo di opzione |
---|---|---|---|---|---|---|---|
0.046EUR | +4.55% | - Quantità in denaro: - |
- Quantità in lettera: - |
JOHNSON + JOHNSON ... | 260.00 - | 19/12/2025 | Call |
GlobeNewswire
28/05
Numab Therapeutics Announces Johnson & Johnson to Acquire its Wholly-Owned Subsidiary Yellow Jersey ...
GlobeNewswire
10/04
SWAV Alert: Monsey Firm of Wohl & Fruchter Investigating Fairness of the Sale of Shockwave Medical t...
GlobeNewswire
15/03
CURE Media Group and Oncology Nursing News Announces the 2024 Extraordinary Healer® Award Finalists
GlobeNewswire
04/12/2023
Nanobiotix Announces Closing of the Remaining $4.8 Million Investment From Johnson & Johnson Innovat...